Showing results (1-10 of 559) with videos related to
Sort By:
Pageof 56
Medchemcomm|August 13, 2013
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cellsJonathan F Arambula, Jonathan L Sessler, Zahid H SiddikBioorganic & Medicinal Chemistry Letters|February 25, 2011
Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugateJonathan F Arambula, Jonathan L Sessler, Zahid H SiddikChemistry (Weinheim an Der Bergstrasse, Germany)|June 26, 2014
Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugateGrégory Thiabaud, Jonathan F Arambula, Zahid H Siddik, et al.Anti-Cancer Agents in Medicinal Chemistry|March 2, 2011
Texaphyrins: tumor localizing redox active expanded porphyrinsJonathan F Arambula, Christian Preihs, Derric Borthwick, et al.Chemical Communications (Cambridge, England)|October 6, 2010
Bismuth- and lead-texaphyrin complexes: towards potential α-core emitters for radiotherapyChristian Preihs, Jonathan F Arambula, Vincent M Lynch, et al.Chemical Communications (Cambridge, England)|August 21, 2019
Expanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugationSajal Sen, Yue Li, Vincent Lynch, et al.Angewandte Chemie (International Ed. in English)|July 6, 2016
Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox MediatorGregory Thiabaud, Rebecca McCall, Guangan He, et al.Journal of the American Chemical Society|September 22, 2010
A pyrrolyl-based triazolophane: a macrocyclic receptor with CH and NH donor groups that exhibits a preference for pyrophosphate anionsJonathan L Sessler, Jiajia Cai, Han-Yuan Gong, et al.Dalton Transactions (Cambridge, England : 2003)|December 22, 2009
Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell linesJonathan F Arambula, Jonathan L Sessler, Mark E Fountain, et al.Pageof 56